Raphas Co., Ltd.
Research Raphas Co., Ltd. (214260.KQ) on Bullrun: market cap KRW 61.89B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker214260.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 61.89B
- Financial periodQ2 2026
- RevenueKRW 7.58B
- Net income-KRW 1.91B
- Free cash flowKRW 458.88M
- Gross margin37.8%
Valuation Snapshot
latest market cap is KRW 61.89B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 61.89B | n/a | n/a | n/a |
Dividend history
About Raphas Co., Ltd.
Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organization services. The company was incorporated in 2006 and is based in Seoul, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Raphas Co., Ltd.'s market cap?
Raphas Co., Ltd.'s market capitalization is KRW 61.89B.
What does Raphas Co., Ltd. do?
Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organization services. The company was incorporated in 2006 and is based in Seoul, South Korea.